IGF2BP2 and familial pancreatic carcinoma: In pancreatic cancer, genomic mutation analysis based on the cBioPortal database reveals that the IGF2BP2 locus is amplified in 15.25% of patients, indicating that the overexpression of IGF2BP2 is highly correlated with CNV 107.